Larry Smith
@SmithOnStocks1
Followers
278
Following
8
Media
0
Statuses
43
Joined October 2020
$nwbo I have taken the transcript from Linda Power’s comments at the annual meeting and edited and organized them to make for easier reading. It contains a wealth of valuable information. I have also included my key takeaways. The report is free .
smithonstocks.com
Glossary of Key Acronyms Used in this Report MHRA Medicines and Healthcare products Regulatory Agency is the United Kingdom regulatory counterpart to FDA. The two agencies have a close, collegial...
10
32
134
The decision on Citadel, et al's motion to dismiss is likely to be released in four to six weeks. This leads me to republish a report on this issue earlier this year.
smithonstocks.com
Key Points: I believe that the lawsuit will be allowed to go to discovery before or around mid-year. This will allow access to the trading records and computer algorithms used by market makers to...
0
9
41
$NWBO I have just published a new report on the lawsuit. It can be accessed at this link. https://t.co/MU6eqJKgTd Ignore the message that you need to subscribe to access the report. It is free.
smithonstocks.com
Key Points: I believe that the lawsuit will be allowed to go to discovery before or around mid-year. This will allow access to the trading records and computer algorithms used by market makers to...
3
22
99
I published a report last week "Highly Probable UK Approval of DCVax-L in 1H, 2024 Would Be a Crowning Achievement" for Northwest Biotherapeutics https://t.co/DFO5oBKC3L Firewall issues prevented some from seeing it, but this has been corrected. The report is free.
smithonstocks.com
Key Points: On December 21, 2023, NWBO announced that it had submitted its MAA seeking regulatory approval for DCVax-L in the UK. The Company requested that MHRA review DCVax-L using the accelerated...
9
27
102
$nwbo I have summarized my latest thoughts on NWBO in a report “Highly Probable UK Approval of DCVax-L in 1H, 2024 Would Be a Crowning Achievement for Northwest Biotherapeutics”. This can be accessed free of charge at this link.
smithonstocks.com
Key Points: On December 21, 2023, NWBO announced that it had submitted its MAA seeking regulatory approval for DCVax-L in the UK. The Company requested that MHRA review DCVax-L using the accelerated...
7
30
125
I wrote this report on the importance of the approval for the commercial manufacturing of DCVax-L at Sawston last April. Thought I would republish.
smithonstocks.com
Acronyms Used in This Report MHRA Medicines and Healthcare products Regulatory Agency is the United Kingdom regulatory counterpart to FDA. The two agencies have a close, collegial working relations...
4
18
79
$nwbo Why I believe that NWBO has been the subject of a collusion between market makers and hedge funds to artificially drive the price to levels orders of magnitude below it would be without the manipulation.
smithonstocks.com
DCVax-L Impressive Phase 3 Results Are Validated by Independent, Expert Scientists and Physicians; Supports Strong Upward Stock Move The final results of the phase 3 trial of DCVax-L were first...
8
34
115
$nwbo The commercial licensing of Sawston likely confers to it a value of several hundred million dollars. This is a new and very important part of the NWBO inv thesis apart from DCVax-L. See my report.
smithonstocks.com
Acronyms Used in This Report MHRA Medicines and Healthcare products Regulatory Agency is the United Kingdom regulatory counterpart to FDA. The two agencies have a close, collegial working relations...
12
40
122
$nwbo Feuerstein continues to gaslight the DCVax-L phase 3 trial falsely claiming that the endpoint was PFS. Here are the actual facts.
smithonstocks.com
Executive Summary I have tried to make this report as short and readable as possible so that in many cases I provide links to a previous article I have written or other pertinent data, rather than...
7
40
111
$NWBO Here are some insights into Adam Feuerstein's decade long assault against NWBO. https://t.co/LWIlxY7ZUV
smithonstocks.com
Introduction Let me ask you a question? If Adam Feuerstein is trying to convince you that DCVax-L has no chance of being effective in glioblastoma multiforme (GBM), wouldn’t you expect him to have a...
2
14
55
$NWBO Creating counterfeit shares through illegal naked shorting is at the heart of Wall Street's rampant manipulation of securities, which by some estimates accounts for as much as 20% of Street profits. In part, this is how it is done with stocks.
smithonstocks.com
Acronyms Used Frequently in This Report DTCC: The Depository Trust & Clearing Corporation (DTCC) provides clearing and settlement services to the US financial markets that handle the exchange of...
0
13
46
$NWBO Feuerstein says there is no spoofing or market manipulation. His old firm https://t.co/1cnJB3mZ6X disagrees. https://t.co/yza0qBFq2I Also Citadel just paid a $10 million fine in Japan for spoofing.
6
25
97
$NWBO $GNS Creating counterfeit shares through illegal naked shorting is at the heart of Wall Street's rampant manipulation of securities, which by some estimates accounts for as much as 20% of Street profits. In part, this is how it is done with stocks.
smithonstocks.com
Acronyms Used Frequently in This Report DTCC: The Depository Trust & Clearing Corporation (DTCC) provides clearing and settlement services to the US financial markets that handle the exchange of...
1
10
40
$NWBO Feuerstein says there is no spoofing or market manipulation. His old firm https://t.co/1cnJB3mZ6X disagrees. https://t.co/yza0qBFq2I Also Citadel just paid a $10 million fine in Japan for spoofing.
6
25
97
$NWBO Investors don't own shares of NWBO. They are owned by CEDE, a subsidiary of DTCC which in turn is owned by Wall Street firms. You own a fungible, digital derivative of registered shares which is key to creation of counterfeit shares. See
smithonstocks.com
You Really Don’t Own the Shares that Appear in Your Brokerage Account; They Belong to Cede Most investors when they buy a publicly traded stock believe that they own a part of some company. They...
4
10
44
$NWBO Investors don't own shares of NWBO. They are owned by CEDE, a subsidiary of DTCC which in turn is owned by Wall Street firms. You own a fungible, digital derivative of registered shares which is key to creation of counterfeit shares. See
smithonstocks.com
You Really Don’t Own the Shares that Appear in Your Brokerage Account; They Belong to Cede Most investors when they buy a publicly traded stock believe that they own a part of some company. They...
4
10
44
$nwbo Comments on FDA Guidance for Use of Contemporaneous External Controls; Importance for DCVax-L
smithonstocks.com
The FDA just issued new guidance on the use of contemporaneous external controls in clinical trials. Hedge funds who are massively short Northwest Biotherapeutics stock have falsely argued that the...
5
19
74
$nwbo New report on stock price behavior of NWBO that you should find interesting.
smithonstocks.com
DCVax-L Impressive Phase 3 Results Are Validated by Independent, Expert Scientists and Physicians; Supports Strong Upward Stock Move The final results of the phase 3 trial of DCVax-L were first...
4
5
31
$nwbo If you suspect that NWBO stock price is being manipulated, you might want to read this.
smithonstocks.com
DCVax-L Impressive Phase 3 Results Are Validated by Independent, Expert Scientists and Physicians; Supports Strong Upward Stock Move The final results of the phase 3 trial of DCVax-L were first...
2
17
59
$NWBO Putting the extremely important peer reviewed JAMA article on DCVax-L in perspective
smithonstocks.com
Overview This article puts into perspective the importance of a peer reviewed article on the Phase 3 Trial of murcidencel (better known as DCVax-L) that was published today in JAMA Oncology, A...
1
14
64